Metraipolis › archive › dc_ab340eac63f0
CD63-Mediated SARS-CoV-2 RBD Fusion Neoantigen DNA Vaccine Enhances Antitumor Immune Response in a Mouse Panc02 Model via EV-Targeted Delivery — Europe PMC PMID:41012180
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41012180
- DOI
- 10.3390/vaccines13090977
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T22:53:41.472Z
- SHA-256 of the archived text
9ec58922d010d358ebcfc99872ef91edaaeea5f082322ee29fc689336d04eb97- Stable URL of this page
https://metraipolis.com/documento/dc_ab340eac63f0
How to cite
CD63-Mediated SARS-CoV-2 RBD Fusion Neoantigen DNA Vaccine Enhances Antitumor Immune Response in a Mouse Panc02 Model via EV-Targeted Delivery — Europe PMC PMID:41012180 — Europe PMC (en), https://europepmc.org/article/MED/41012180 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ab340eac63f0 (Metraipolis archive dc_ab340eac63f0, sha256 9ec58922d010d358ebcfc99872ef91edaaeea5f082322ee29fc689336d04eb97)
BibTeX
@misc{dcab340eac63f0,
title = {CD63-Mediated SARS-CoV-2 RBD Fusion Neoantigen DNA Vaccine Enhances Antitumor Immune Response in a Mouse Panc02 Model via EV-Targeted Delivery — Europe PMC PMID:41012180},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41012180},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ab340eac63f0; sha256 9ec58922d010d358ebcfc99872ef91edaaeea5f082322ee29fc689336d04eb97},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41012180. Agents can read the archived copy with the MCP tool read_document.